Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance

British Journal of Cancer

Volumn 86, Issue 11, 2002, Pages 1790-1796

  Luo, L Y ^a,b   Diamandis, E P ^a,b   Look, M P ^c   Soosaipillai, A P ^a   Foekens, J A ^c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer prognosis; Human kallikrein 10; Human kallikrein 6; Response to treatment; Survival; Tamoxifen therapy

Indexed keywords

ESTROGEN RECEPTOR; KALLIKREIN; KALLIKREIN 10; KALLIKREIN 6; PROGESTERONE RECEPTOR; SERINE PROTEINASE; TAMOXIFEN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; CHROMOSOME 19Q; CORRELATION ANALYSIS; DOWN REGULATION; DRUG RESPONSE; FEMALE; FLUOROMETRY; GENE CLUSTER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; CYTOSOL; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; KALLIKREINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TAMOXIFEN;

EID: 0037024408     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600323     Document Type: Article

References (44)

1. Relationship between estrogen receptor concentration and clinical and histological factors: Their relative prognostic importance after radical masterectomy for primary breast cancer
2. A novel protease homolog differentially expressed in breast and ovarian cancer
3. Molecular aspects of tumor cell invasion and metastasis
4. The molecular biology of the kallikreins and their roles in inflammation (1997)
5. Thrombin signalling and protease-activated receptors
6. Laminin receptors, collagenase IV and prognosis in node-negative breast cancer
7. New nomenclature for the human tissue kallikrein gene family
8. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
9. Human kallikrein 6 (zyme/protease M/neurosin): A new serum biomarker of ovarian carcinoma
10. Prostate-specific antigen: A cancer fighter and a valuable messenger?
11. Role of proteolytic enzymes in cancer invasion and metastasis
12. Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E. O. R. T. C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute
13. Prognostic value of estrogen receptors and progesterone receptors measured by enzyme immunoassays in human breast cancer
14. Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer
15. Plasminogen activator inhibitor-1 and breast cancer prognosis
16. Expression of prostate specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
17. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
18. The role for NES1 serine protease as a novel tumor suppressor
19. Non-parametric estimation from incomplete observations
20. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptor
21. Mechanism of androgen receptor activation and possible implications for chemoprevention trials
22. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2
23. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzeimer's disease brain
24. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
25. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression
26. Clinical relevance of the urokinase plasminogen activator system in breast cancer
27. Structural characterization and mapping of the normal epithelial cell-specific 1 gene
28. The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474
29. Immunofluorometric assay of human kallikrein 10 and its detection in biological fluids and tissues
30. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumor suppressor gene in normal and malignant testicular tissue
31. Human kallikrein 10 (normal epithelial cell-specific 1, NES1): A novel tumor marker for ovarian carcinoma?
32. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma
33. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
34. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues, as assessed by immunohistochemistry
35. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of a prospective Southwest Oncology Group Study
36. Breast Cancer
37. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
38. Characterization of the precursor of prostate-specific antigen-activation by trypsin and by human glandular kallikrein
39. Association between high concentrations of Mr 52, 000 cathepsin D and poor prognosis in primary human breast cancer
40. The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast
41. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain
42. Molecular characterization of zyme/protease M/neurosin, a hormonally-regulated kallikrein-like serine protease
43. The new human tissue kallikrein gene family: Structure, function, and association to disease